Showing 61 - 80 results of 37,069 for search '(( significant based basic ) OR ( significant ((genes decrease) OR (mean decrease)) ))', query time: 1.17s Refine Results
  1. 61

    Osr1 heterozygous mice experienced decreased bile acid synthesis in the liver. by Ernest C. Lynch (12769954)

    Published 2022
    “…Osr1 female mice had significantly increased gene expression of <i>Plin4</i> and <i>Plin5</i>. …”
  2. 62
  3. 63

    GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. by Nicole K. Polinski (10947787)

    Published 2021
    “…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …”
  4. 64

    Brain and liver GCase activity are significantly decreased in heterozygous <i>GBA1</i> D409V KI mice, with varying differences in glucosphingolipid lipids in brain and liver. by Nicole K. Polinski (10947787)

    Published 2021
    “…Abbreviations: GlcCer, glucosylceramide; GlcSph, glucosylsphingosine; <i>GBA1</i>, gene encoding human glucocerebrosidase; GCase, glucocerebrosidase; WT, wild type; HET, heterozygous; KI, knockin; SEM, standard error of the mean; mo, month; ns, non-significant (<i>p</i> > 0.05).…”
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70

    Cycloheximide (CHX) treatment decreases production of rRNA transcripts by POLR1 and POLR3. by Martin Selinger (3195987)

    Published 2019
    “…Data are representative of three independent experiments and values are expressed as mean with SEM. Significant difference from the control was calculated using one-sample Student’s t-test (* P<0.05). …”
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…(n = 3 - 10 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.).…”
  16. 76

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
  17. 77
  18. 78
  19. 79
  20. 80

    GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

    Published 2022
    “…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).…”